| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9237705 | Digestive and Liver Disease | 2005 | 6 Pages |
Abstract
Once-daily levofloxacin plus azithromycin-based triple therapy achieves an H. pylori eradication rate comparable to that of standard twice-daily triple therapy, but is associated with higher patient compliance and might even be better tolerated.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
F. Iacopini, P. Crispino, O.A. Paoluzi, A. Consolazio, R. Pica, M. Rivera, D. Palladini, F. Nardi, P. Paoluzi,